MedPath

Prognostic Assessment for Patients Notified as Dual Obstructive Atherosclerosis Requiring Angioplasties

Not Applicable
Recruiting
Conditions
Coronary artery disease, Carotid artery disease
Registration Number
JPRN-UMIN000015427
Lead Sponsor
Department of Cardiology, Fujita Health University
Brief Summary

The prevalence of TVD/LMT and HRP determined by coronary CTA is higher in patients needing CAS/CEA than in those without. Management of systemic atherosclerosis is required in the perioperative period of CAS/CEA.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Those who underwent coronary artery bypass grafting Those who have severe chronic lidney disease (estimated glomerular filtration rate <30mL/min/1.73m2) Those who have iodinated contrast medium allergy Those who are not willing to participate in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
composite of adverse events (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and revascularization for carotid or coronary artery)
Secondary Outcome Measures
NameTimeMethod
all-cause death, non-fatal myocardial infarction, non-fatal stroke, and revascularization for carotid or coronary artery, admission due to congestive heart failure, and fatal arrhythmia
© Copyright 2025. All Rights Reserved by MedPath